These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Psychopharmacological studies on (--)-nuciferine and its Hofmann degradation product atherosperminine. Bhattacharya SK; Bose R; Ghosh P; Tripathi VJ; Ray AB; Dasgupta B Psychopharmacology (Berl); 1978 Sep; 59(1):29-33. PubMed ID: 100809 [TBL] [Abstract][Full Text] [Related]
27. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]
28. Prenatal exposure to cocaine reduces dopaminergic D1-mediated motor function but spares the enhancement of learning by amphetamine in rabbits. Simansky KJ; Baker G; Kachelries WJ; Hood H; Romano AG; Harvey JA Ann N Y Acad Sci; 1998 Jun; 846():375-8. PubMed ID: 9668429 [No Abstract] [Full Text] [Related]
29. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123]. Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780 [TBL] [Abstract][Full Text] [Related]
30. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors. Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320 [TBL] [Abstract][Full Text] [Related]
31. Effect of muscarinic receptor agonists on animal models of psychosis. Karan RS; Ravishankar P; Pandhi P Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):169-72. PubMed ID: 10893700 [TBL] [Abstract][Full Text] [Related]
32. Behavioral pharmacology of the benzamides as compared to standard neuroleptics. Worms P Adv Biochem Psychopharmacol; 1982; 35():7-16. PubMed ID: 6128876 [No Abstract] [Full Text] [Related]
34. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis. Dall'Igna OP; Tort AB; Souza DO; Lara DR J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988 [TBL] [Abstract][Full Text] [Related]
35. Suppression of opiate withdrawal and cocaine hyperarousal syndromes by buspirone. Possible pharmacotherapeutic applications. Aceto MD; Bowman ER Arzneimittelforschung; 1993 Sep; 43(9):942-5. PubMed ID: 8240454 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacologic studies on the effect of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on the vegetative and central nervous system]. Rostock A; Hoffmann W; Ploen U; Bartsch R Pharmazie; 1985 Dec; 40(12):875-8. PubMed ID: 3841610 [TBL] [Abstract][Full Text] [Related]
37. Clonidine: new research in psychotropic drug pharmacology. Fielding S; Lal H Med Res Rev; 1981; 1(1):97-123. PubMed ID: 7050562 [No Abstract] [Full Text] [Related]
38. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001 [TBL] [Abstract][Full Text] [Related]
39. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor. Izzo E; Sanna PP; Koob GF Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]